These rules keep the foreign-trained stock low relative to peer countries. Denmark’s practicing physician density stood at 466.4 per 100,000 inhabitants in 2024. The combination of central dimensioning, domestic priority in the KBU allocation, and a reversible zero quota on non-EU entry produces the 10–12% range that other Western systems have not matched.
Situation in other Western States
OECD figures for 2021–2023 show the United States at 25.0% foreign-trained (215,630 physicians), the United Kingdom at 38.3% (77,793), and Germany at 15.0% (58,449, though German data often count foreign citizenship rather than place of training). Specialists and surgeons, the people treating the grandparents and children of the peoples of the West, are particularly composed of third-world trained physicians.
In the United States, the AAMC’s 2024–2025 data put international medical graduates (IMGs) at 25.6% of active physicians. The FSMB 2024 census of licensed physicians recorded 23% IMGs (approximately 5% US-citizen IMGs and 18% non-US IMGs). Among residents in 2024–2025, IMGs comprised 24.2%. In the 2025 Match, non-US citizen IMGs filled 45% of categorical internal medicine positions and 31% of family medicine positions. These shares occur inside a system in which Medicare GME payments fund the majority of residency slots without a statutory preference for US medical school graduates. In other words, American taxpayers are shelling out billions of dollars to fund the training of foreign medical doctors and the demographic replacement in both this sector and your neighborhood.
In the United Kingdom the GMC’s 2025 workforce report states that doctors who qualified outside the UK make up 42% of those holding a license to practice, or some 138,405 individuals. In 2024, 20,060 non-UK qualified doctors joined the register against 10,384 UK graduates. Among doctors in training, 28% (22,027 of 79,171) held a non-UK primary medical qualification in 2024. Specialty training offer rates in 2023/24 stood at 69% for UK graduates and 23% for non-UK graduates. Half of first-year GP trainees in 2024 had qualified outside the UK.
In Germany, Destatis reported that 64,000 physicians (13% of the total) held no German citizenship in 2024, up from 30,000 (7%) in 2014. Including those who had naturalized, 121,000 physicians with an immigrant background worked in human and dental medicine, equal to 24% of the workforce. Roughly 7,000 foreign medical degrees received full equivalence recognition in 2024. Foreign-trained or foreign-citizen doctors are concentrated in hospital employment; state-level data show shares well above the national average in inpatient internal medicine, surgery, and anesthesiology in several Länder.
These numbers track the absence of the Danish mechanisms: no binding dimensioning of training places to domestic graduate output, no first-round priority for domestic graduates in the US Match or UK specialty recruitment, and no federal cap on new recognitions in Germany.
United States
Policies can rectify this situation. Nationalist, common-sense policies.
In a new appropriation cycle, GME-receiving hospitals must give first-round consideration to graduates of LCME- and COCA-accredited schools before ranking any other applicant. The preference is defined by place of medical education, not citizenship, so that this policy can survive equal-protection review by current courts. US citizen IMGs who graduated from non-accredited foreign schools fall outside the preference, but this is unavoidable at this time. Specialty specific ceilings can also accompany the preference: internal medicine and family medicine, the two highest-volume IMG destinations, are capped at a declining maximum foreign-trained share of filled positions (beginning at the 2025 levels of 45% and 31% and falling by 5 percentage points per year). Hospitals that exceed the ceiling lose a proportionate share of GME (taxpayer) funding the following year. Compliance is verified through existing NRMP and CMS data; results must be published annually by specialty and by hospital.
Domestic capacity will expand on a published five-year schedule before the ceilings bind hard. US medical-school enrollment and the number of Medicare-funded residency positions in the targeted specialties will rise in parallel, so that total training output does not fall. The AAMC’s 1,032,365 active-physician count supplies the starting point; the schedule can be sized to replace the foreign-trained inflow on a one-for-one basis by year five while still allowing modest net growth. J-1 and H-1B rules, if not entirely scrapped as immigration categories, must be rewritten so that residency training confers no expectation of permanent status or subsequent employment by American institutions.
The 7.1% of residents currently on J-1/J-2 visas in the 2024–2025 census would become a temporary population whose departure is expected at the end of training.
After the training pipeline is reoriented, recruitment rule must naturally follow. Hospitals and practices that receive federal payments (Medicare, Medicaid, or federal grants) must document that they offered any open attending or employed position first to physicians who completed both medical school and residency in the United States before extending an offer to a foreign-trained physician. The same declining ceilings used in training can then apply to new hires. Geographic and specialty shortages can be addressed by temporary, location-specific incentives available only to US-trained physicians such as: loan repayment, higher GME weights, or accelerated credentialing.
All of these things are better than open recruitment abroad and a medical service staffed by strangers rather than Americans. The measurable endpoint is a foreign-trained share of the active physician workforce below 10%, reached by combining the training preference, the hiring preference, natural attrition of the existing IMG stock, and continued domestic expansion.
United Kingdom
As previously mentioned, 42% of current licensed doctors (138,405) are qualified outside the UK; and in 2024 alone, some 20,060 non-UK doctors joined the register against 10,384 British graduates. Additionally, roughly 28% of doctors in training hold a non-UK primary medical qualification. The Medical Training (Prioritisation) powers already permit the Secretary of State to direct that UK graduates receive first consideration. Those powers must be converted from advisory to binding for both Foundation and specialty training so that British graduates are offered every available post before any non-UK graduate is considered. Annual declining targets for the non-UK share of new training acceptances must be published (starting from the 36% of specialty offers taken by non-UK graduates in 2023/24 and falling by at least 5 percentage points per year). Offer rates can be tracked separately; the 69% UK versus 23% non-UK gap in 2023/24 becomes yet another target to reduce to the possible smallest margin for non-British graduates.
Undergraduate expansion must be reworked so that a broad specialty-training expansion can take place across a multi-year schedule. Medical-school places increase only when corresponding Foundation and specialty posts are funded and staffed, eliminating the current mismatch that drives the 28% non-UK share among doctors in training. Residual entry for non-UK graduates must be limited annually as requirements for foreign doctors decrease with the training of UK medical practitioners.
Recruitment follows the same logic once the training pipeline is controlled. NHS employers must offer any consultant, SAS, or GP post first to doctors who completed both primary qualification and postgraduate training to a British national. The declining ceiling applied to training acceptances can then be extended to new hires. Retention of UK-trained doctors can be reinforced by preferential consultant appointments and by service obligations attached to NHS-funded training places. The target is a foreign-qualified share of the licensed workforce below 10% for doctors, specialists, and nurses.
Germany
To remind readers: Destatis recorded 64,000 physicians without German citizenship (13%) and 121,000 with an immigrant background (24%) in 2024. A new federal-Länder framework can establish annual target numbers for Weiterbildung places dimensioned to the output of German medical faculties, assuring that German doctors service the German population. Publicly funded or authorized training posts must give first consideration to German nationals who obtained after study at a German or other European university (where thousands of German students kept from their own universities currently study). A residual quota for all other applicants can be established and that quota must decline by at least 5 percentage points per year from the current baseline. Germany’s current constitutional situation also mandates that new rules be written to remain compatible with EU free-movement for automatic recognition of other EU qualifications; the residual quota and the recognition cap operate within that constraint by limiting the volume of new non-German-university entrants rather than by discriminating against EU citizens as such. At the very least, it will push out non-Western medical practitioners.
Language and adaptation standards can, within reason, be harmonized upward across the Länder and made a precondition for any training post and hire into a German medical practice. Because most specialist training occurs inside hospital employment contracts, the priority rule is enforced through the conditions attached to public funding and to the authorization of training posts by the state medical associations. Non-compliant hospitals lose a proportionate share of public funding or training authorization the following year. German institutions must hire German (and European) medical practitioners.
Once the training pipeline is reoriented, recruitment rules must expand to apply to full time, fully qualified positions. Hospitals and practices that receive public funding must prove that they offered any open post to physicians who completed both medical school and specialist training to German (and EU) citizens. Natural attrition of the existing foreign-trained stock, combined with the capped recognition volume and the domestic-priority hiring rule, will produce a steady decline in the overall share of foreign doctors in the country.
Temporary bridging incentives for shortage regions remain available only to German-trained physicians. The measurable endpoint is a foreign-trained (or non-German-university) share of the physician workforce below 10%. Annual Destatis and Bundesärztekammer statistics supply the public dashboard; a federal-Länder review is required at year five.
In each country the sequence is identical: reorient the training pipeline with a binding domestic-priority rule and declining ceilings, expand domestic places on a published schedule so that total output does not fall, extend the same priority and ceilings to recruitment and hiring, and use temporary, domestically restricted incentives to protect access in high-dependency areas. The <10% stock target is reached by the combination of lower inflows, natural attrition, and continued domestic expansion, tracked against the existing AAMC, GMC, and Destatis series.
Denmark’s 11.7% foreign-trained share is not an accident of geography or of the Kingdom’s small population. It is the recorded result of a nationalist and pragmatic policy oriented to maximize domestic graduate numbers, priority allocation to those graduates, and a reversible zero quota on new non-EU/EEA authorizations.
The Danish example and their policies are, in broad strokes, compatible with the institutional structures of the United States, the United Kingdom, Germany, and almost any Western country. Their adoption would return control of the size and composition of the physician workforce to the national authorities that already fund and authorize the training places.